BALYASNY ASSET MANAGEMENT L.P. - LUX HEALTH TECH ACQUISITION ownership

LUX HEALTH TECH ACQUISITION's ticker is LUXA and the CUSIP is 55068A100. A total of 72 filers reported holding LUX HEALTH TECH ACQUISITION in Q2 2022. The put-call ratio across all filers is 4.67 and the average weighting 1.3%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of LUX HEALTH TECH ACQUISITION
ValueSharesWeighting
Q3 2022$12,438,000
+1.2%
1,242,551
+0.0%
0.04%
-5.0%
Q2 2022$12,288,000
+0.3%
1,242,5100.0%0.04%
+2.6%
Q1 2022$12,251,000
+0.6%
1,242,5100.0%0.04%
-7.1%
Q4 2021$12,177,000
-0.1%
1,242,5100.0%0.04%
-17.6%
Q3 2021$12,189,000
-0.8%
1,242,5100.0%0.05%
-12.1%
Q2 2021$12,288,000
+79.2%
1,242,510
+86.0%
0.06%
+70.6%
Q1 2021$6,859,000667,8660.03%
Other shareholders
LUX HEALTH TECH ACQUISITION shareholders Q2 2022
NameSharesValueWeighting ↓
Wolfswood Holdings, LLC 2,000,000$19,720,00081.59%
MYDA Advisors LLC 970,000$9,564,0003.78%
RP Investment Advisors LP 1,309,486$12,912,0001.81%
Tuttle Capital Management, LLC 41,697$411,0001.02%
Silver Rock Financial LP 369,442$3,643,0000.69%
Empyrean Capital Partners, LP 3,000,649$29,586,0000.65%
BBR PARTNERS, LLC 639,999$6,310,0000.60%
Governors Lane LP 725,000$7,149,0000.52%
Spartan Fund Management Inc. 226,753$2,795,0000.46%
Senator Investment Group LP 1,473,600$14,530,0000.45%
View complete list of LUX HEALTH TECH ACQUISITION shareholders